International Events 2014.
- Published in:
- 2013
- Publication type:
- Calendar
Works matching IS 20412177 AND DT 2013 AND VI 5 AND IP 4
Results: 41
1
2
The economic impact of multiple sclerosis in Australia in 2010.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 4, p. 121
- By:
- Publication type:
- Article
3
Immunomodulatory and therapeutic effects of Hot-nature diet and co-supplemented hemp seed, evening primrose oils intervention in multiple sclerosis patients.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 4, p. 121
- By:
- Publication type:
- Article
4
Migraine headaches and pain with neuropathic characteristics: comorbid conditions in patients with multiple sclerosis.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 4, p. 120
- By:
- Publication type:
- Article
5
Consensus guidelines on the neurologist's role in the management of neurogenic lower urinary tract dysfunction in multiple sclerosis.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 4, p. 119
- By:
- Publication type:
- Article
6
Multiple Sclerosis Outcome Assessments Consortium: Genesis and initial project plan.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 4, p. 118
- By:
- Publication type:
- Article
7
JC-virus seroconversion in multiple sclerosis patients receiving natalizumab.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 4, p. 118
- By:
- Publication type:
- Article
8
Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 4, p. 117
- By:
- Publication type:
- Article
9
Magnetic resonance monitoring of lesion evolution in multiple sclerosis.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 4, p. 116
- By:
- Publication type:
- Article
10
Wallerian and trans-synaptic degeneration contribute to optic radiation damage in multiple sclerosis: a diffusion tensor MRI study.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 4, p. 116
- By:
- Publication type:
- Article
11
Cerebral white matter blood flow and energy metabolism in multiple sclerosis.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 4, p. 115
- By:
- Publication type:
- Article
12
A 10-year follow-up of a population-based study of people with multiple sclerosis in Stockholm, Sweden: changes in disability and the value of different factors in predicting disability and mortality.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 4, p. 114
- By:
- Publication type:
- Article
13
Season of infectious mononucleosis and risk of multiple sclerosis at different latitudes; the EnvIMS Study.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 4, p. 114
- By:
- Publication type:
- Article
14
Incidence and prevalence of multiple sclerosis in the UK 1990-2010: a descriptive study in the General Practice Research Database.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 4, p. 113
- By:
- Publication type:
- Article
15
Hospital admission due to infections in multiple sclerosis patients.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 4, p. 113
- By:
- Publication type:
- Article
16
Epidemiology in multiple sclerosis: a pilgrim's progress.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 4, p. 112
- By:
- Publication type:
- Article
17
A regenerative approach to the treatment of multiple sclerosis.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 4, p. 111
- By:
- Publication type:
- Article
18
Transdermal application of myelin peptides in multiple sclerosis treatment.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 4, p. 111
- By:
- Publication type:
- Article
19
Switching from natalizumab to fingolimod: an observational study.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 4, p. 110
- By:
- Publication type:
- Article
20
Magnetic resonance imaging outcomes from a Phase III trial of teriflunomide.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 4, p. 109
- By:
- Publication type:
- Article
21
4-Aminopyridine ameliorates mobility but not disease course in an animal model of multiple sclerosis.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 4, p. 109
- By:
- Publication type:
- Article
22
Interferon beta 1b following natalizumab discontinuation: one year, randomized, prospective, pilot trial.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 4, p. 108
- By:
- Publication type:
- Article
23
Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 4, p. 107
- By:
- Publication type:
- Article
24
Immune competence after alemtuzumab treatment of multiple sclerosis.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 4, p. 107
- By:
- Publication type:
- Article
25
Teriflunomide versus subcutaneous interferon beta-1 a in patients with relapsing multiple sclerosis: a randomised, controlled Phase 3 trial.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 4, p. 106
- By:
- Publication type:
- Article
26
The B1-cell subpopulation is diminished in patients with relapsing-remitting multiple sclerosis.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 4, p. 105
- By:
- Publication type:
- Article
27
Xanthine oxidase mediates axonal and myelin loss in a murine model of multiple sclerosis.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 4, p. 105
- By:
- Publication type:
- Article
28
Parasite infections in multiple sclerosis modulate immune responses through a retinoic acid-dependent pathway.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 4, p. 104
- By:
- Publication type:
- Article
29
Kinetics of IL-6 production defines T effector cell responsiveness to regulatory T cells in multiple sclerosis.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 4, p. 103
- By:
- Publication type:
- Article
30
Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 4, p. 102
- By:
- Publication type:
- Article
31
Post-acute serum eosinophil and neutrophil-associated cytokine/chemokine profile can distinguish between patients with neuromyelitis optica and multiple sclerosis; and identifies potential pathophysiological mechanisms - a pilot study.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 4, p. 103
- By:
- Publication type:
- Article
32
IL-22 secreting CD4<sup>+</sup> T cells in the patients with neuromyelitis optica and multiple sclerosis.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 4, p. 101
- By:
- Publication type:
- Article
33
Neuromyelitis optica IgG causes placental inflammation and fetal death.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 4, p. 101
- By:
- Publication type:
- Article
34
Neuromyelitis optica and pregnancy.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 4, p. 100
- By:
- Publication type:
- Article
35
T-cell homeostasis in pediatric multiple sclerosis: old cells in young patients.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 4, p. 99
- By:
- Publication type:
- Article
36
L-selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 4, p. 99
- By:
- Publication type:
- Article
37
Clinically silent PML and prolonged immune reconstitution inflammatory syndrome in a patient with multiple sclerosis treated with natalizumab.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 4, p. 98
- By:
- Publication type:
- Article
38
The influence of vitamin D supplementation on melatonin status in patients with multiple sclerosis.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 4, p. 98
- By:
- Publication type:
- Article
39
Resting-state functional connectivity in multiple sclerosis: an examination of group differences and individual differences.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 4, p. 97
- By:
- Publication type:
- Article
40
Rehabilitative Strategies for Gait Dysfunction in Persons with Multiple Sclerosis: A Review.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 4, p. 89
- By:
- Publication type:
- Article
41
Foreword.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 4, p. IV
- Publication type:
- Article